恆順醋業(600305.SH):高雲海辭去營銷總監職務
格隆匯 7 月 13日丨恆順醋業(600305.SH)公佈,公司近日收到公司營銷總監高雲海的書面辭職報告,高雲海因工作調動,請求辭去公司營銷總監職務,公司接受了高雲海的辭職申請。辭職後,高雲海不再擔任營銷總監職務,其仍為公司董事。公司對高雲海在擔任營銷總監期間為公司發展所作出的貢獻表示衷心感謝。
經公司決策,公司決定由李國權兼任營銷總監。
李國權,男,1976年生,碩士學位、博士在讀,高級工程師。現任江蘇恆順集團有限公司董事,江蘇恆順醋業股份有限公司董事、總經理。歷任公司研究所副所長、生產部副經理,江蘇恆順調味食品有限公司工藝設備部經理,公司生產部經理,公司研發部經理,公司生產倉儲物流部經理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.